Clinical Trial Update: Efficacy and Safety of Actiponin on Antiobesity in Obese Korean Subjects. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in obese Korean subjects evaluated the efficacy and safety of Actiponin for antiobesity; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Actiponin

Snippet

Sponsor: Chonbuk National University Hospital | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2014-04-21